The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMBAC FINL GROUP INC | COM NEW | 023139884 | 3,047 | 268,457 | SH | SOLE | 268,457 | 0 | 0 | ||
ARBUTUS BIOPHARMA CORP | COM | 03879J100 | 9,490 | 3,501,876 | SH | SOLE | 3,501,876 | 0 | 0 | ||
HERTZ GLOBAL HLDGS INC | *W EXP 06/30/205 | 42806J148 | 402 | 41,013 | SH | SOLE | 41,013 | 0 | 0 | ||
HERTZ GLOBAL HLDGS INC | COM NEW | 42806J700 | 34,212 | 2,159,856 | SH | SOLE | 2,159,856 | 0 | 0 | ||
ODYSSEY MARINE EXPL INC | COM NEW | 676118201 | 4,193 | 1,229,579 | SH | SOLE | 1,229,579 | 0 | 0 | ||
RENREN INC | SPONSORED ADS | 759892300 | 11,500 | 397,655 | SH | SOLE | 397,655 | 0 | 0 | ||
ROIVANT SCIENCES LTD | *W EXP 09/30/202 | G76279119 | 67 | 111,509 | SH | SOLE | 111,509 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 13,919 | 3,419,836 | SH | SOLE | 3,419,836 | 0 | 0 |